Earlier aspects of this case were before us in
Dynan
v. Fritz,
The company (Payne) has appealed from a judgment, entered in April, 1990, that awarded the plaintiffs approximately $392,000 for counsel fees and costs and also made certain other determinations. Payne makes no claim that the amount of the award should be reduced for any reason, but rather, arguing that it received no benefit in this stockholders’ derivative action, Payne challenges the award of any fee at all.
We shall briefly describe certain events since our June, 1987, opinion. In that opinion, we did not decide whether the standard agreement to repurchase stockholders’ shares on death or retirement called for the use of the number of Payne shares outstanding or the number of Payne shares issued on any valuation date. We noted that language in the buy-back agreements presented problems. 2 We suggested that the company might wish to revise the agreements. Id. at 245 n.20. In October, 1987, the Payne stockholders voted to use the number of shares outstanding in valuing repurchased stock and not the number of shares issued. Because the number of Payne shares outstanding was substantially less than the number of shares issued, the shareholders’ decision increased the cost to Payne of repurchasing shares and rejected the opportunity that this case had given Payne to reduce the cost of buying back its shares.
Judgment after rescript, not intended to be a final judgment, was entered in April, 1988. That judgment determined
The April, 1988, judgment also stated that “the Buy-Back Agreement provides for the use of the number of shares issued in calculating repurchase prices, subject to any modification by the parties to the Agreement which may occur or may have occurred subsequent to the issuance of the Supreme Judicial Court’s decision.” Because the stockholders had already voted to use the number of shares outstanding, it is not immediately apparent why this provision was included in the judgment. The issue decided does, however, have a bearing, as we shall see, on the judge’s award of counsel fees to the plaintiffs. The judgment additionally stated that the court would retain jurisdiction to decide the question of counsel fees for the plaintiffs after the stockholders’ vote on the purchase of the Fritz stock.
In July, 1988, the stockholders voted unanimously to ratify the agreement to repurchase the Fritz stock, using the number of shares outstanding in determining the value of Fritz’s stock. The stockholders’ decision resulted in Payne paying substantial amounts to Fritz that would not have been payable if they had not ratified the agreement.
In April, 1990, the judge entered a final judgment that awarded approximately $392,000 in counsel fees and costs to
We are advised that, since final judgment was entered, a corporation has purchased all Payne’s stock. The plaintiffs argue that, because of the sale and the terms of the agreement to sell, all issues in this case, including the issue of counsel fees, are moot. We shall discuss the mootness issue first and, after concluding that the counsel fees issue is not moot, we shall then turn to that issue. Finally, we shall discuss the question whether the judge was correct in concluding that the Fritz shares should be treated as already redeemed for the purpose of valuing the repurchase price of certain shares.
1. The plaintiffs argue that the issues that Payne raises on appeal are moot because, due to changes in circumstances,
The sale of all outstanding shares of Payne stock to an outside purchaser obviously makes unimportant to the parties the proper future application of the stock buy-back agreements. The question whether shares outstanding or shares issued should be used in valuing the stock of a deceased or retired employee, in repurchasing stock under the buy-back agreements, will not arise again among the parties. To the extent, however, that the judge’s ruling in the plaintiffs’ favor on this issue provides a basis for the plaintiffs’ claim for counsel fees, the issue is not moot, unless the counsel fees issue itself is moot. A second question, whether certain shares of the defendant Fritz should have been treated as outstanding on particular dates when Payne stock was repurchased under buy-back agreements, also can have no effect on future events. That issue does have a bearing, however, on the per share prices that Payne must pay to certain stockholders who have sold their shares back to Payne. That issue is, therefore, not moot, unless it is rendered so by the terms of the escrow agreement between the new stockholder and the selling stockholders.
The plaintiffs argue that any obligations to be satisfied pursuant to the judgment in this case are not the responsibility of Payne, against which the judgment has been entered, but rather are the responsibility of the selling shareholders who, it is said, have put aside sufficient funds in an escrow account to satisfy Payne’s contingent obligations, including any amounts to be paid pursuant to the judgment.
The issues in this appeal are not ones in which both parties no longer have a stake. Certainly, the plaintiffs care about an award for attorneys’ fees and about proper payment for stock
In any event, it is difficult to conclude that Payne has no continuing interest in a judgment being entered against it that imposes on it an obligation to pay substantial sums to the plaintiffs, even if, assuming the solvency of the escrow fund, Payne hopes and expects that it will not ultimately be responsible for those amounts. All issues are not moot as the result of the escrow agreement. 3
2. The plaintiffs were entitled to an award of attorneys’ fees. Our cases have acknowledged that a plaintiff in a stockholders’ derivative action is entitled to an award of counsel fees out of whatever proceeds of the action the corporation receives. See
Coggins
v.
New England Patriots Football Club, Inc.,
We return to the shares issued-shares outstanding question. The 1987 rescript from this court did not identify this issue as one for further attention. The trial judge answered it without any explanation for his conclusion and in the face of this court’s conclusion that the agreement was ambiguous. See Dynan v. Fritz, supra at 240. The issue is important in assessing what potential corporate benefit this stockholders’ action created. Certainly, this action resulted in this court’s rejection of an interpretation that the buy-back agreements provided that the number of outstanding shares must be used in valuing shares on repurchase. Id. at 240-241. The plaintiffs’ action, therefore, presented Payne with the opportunity at least to contend at the time of each repurchase that the shares issued approach was the proper one. As our earlier opinion indicates, Payne had been successful for the most part over the years in maintaining this position. Id. at 234-235. The opportunity to maintain this position in the repurchase of shares was a financial benefit to the corporation that justified the award of counsel fees, even though it is not quantifiable in dollars and Payne decided not to take advantage of it.
There is another reason to conclude that an award of counsel fees in this case was appropriate. Equitable considerations are relevant in derivative stockholder actions. Such considerations are most appropriate in dealing with relationships among stockholders in close corporations. See
Donahue
v.
Rodd Electrotype Co.,
3. The judge’s ruling was correct that the Fritz shares should have been treated as no longer outstanding in valuing Payne stock repurchased after January 1, 1987. The stockholders’ vote accepted the terms of the Fritz agreement, and a determination that those shares should be treated as repurchased at the times indicated in the Fritz agreement is logical.
The portion of the judgment concerning the treatment of the Fritz shares in deciding repurchase prices provided no benefit to the corporation. Indeed, it was detrimental to Payne because it has caused Payne to be obliged to pay more for the repurchase of shares than would be the case if the Fritz stock had been treated as outstanding until actually repurchased. The claim that Payne should pay the plaintiffs more for their stock is not a derivative stockholders’ claim. Attorneys’ fees for this portion of the; plaintiffs’ case are not appropriately recoverable as fees in a stockholders’ derivative action. However, Payne attacks the award of attorneys’ fees only in its entirety and never makes a claim that the award should be reduced because it was at least partially wrong. We, therefore, decline to direct a sorting out of the fee award.
We do conclude in our discretion, however, that the plaintiffs are not entitled to an award of counsel fees on appeal. The majority of their brief is devoted to the rejected claim of
Judgment affirmed.
Notes
We said: “The buy-back agreements by which the company may repurchase its stock at a price which may not be closely related to its market value at the time of repurchase is a potential source of continuing trouble, particularly in times when the stock is worth significantly more than its repurchase price. In such circumstances, the incentives to obtain majority control and not to sell treasury stock at cost are strong. Assuming the company’s financial capacity to repurchase shares as they become available on the death or retirement of stockholders, the pressure on continuing stockholders is strong to keep the class of stockholders closed and to seek to be a survivor, as in a joint tenancy or in a tontine.” 400 Mass, at 244-245 n.20.
By agreement, the parties obtained from the Bank of Boston a letter of credit, the terms of which are not in the record, to secure payment of the order for counsel fees if the Superior Court order is affirmed or fees are otherwise ordered on appeal. Presumably, the bank’s obligations under the letter of credit are based on the terms of whatever judgment is entered as a result of the appeal. It is unclear whether the plaintiffs would have any rights under the letter of credit if we were to declare the issue of counsel fees to be moot.
In concluding as we do, we need not decide whether intangible corporate benefits, such as raising the standards of fiduciary relationships (corporate therapeutics), could ever justify an award of attorneys’ fees in a stockholders’ derivative action. Compare
Lewis
v.
Anderson,
